Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
The Motley Fool21d
Is DexCom a Millionaire-Maker Stock?
DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage. Despite several risks, it could deliver substantial returns in the long ...
The Verge28d
This over-the-counter gadget could help the war against diabetes
Dexcom’s new continuous glucose monitor is ... though if you want to share your data with doctors, you can use the free Clarity app. I’m also not sure whether my numbers are good.
Yahoo Finance3d
DexCom, Inc. (DXCM)
I managed to lose seven pounds. SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced ...
Business Insider9d
DXCM STOCK DEADLINE: If You Suffered Losses on Your DexCom, Inc. Investment, Notify BFA Law Before Approaching October 21 Class Action Deadline
New York, New York--(Newsfile Corp. - September 14, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM ...
Morningstar28d
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate glucose sensing technology.5 It is specifically designed to provide the 125 million Americans6 ...
FierceBiotech28d
Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market
After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now ...
Kiplinger1mon
Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know
Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...
Medscape5d
CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated
Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...
Nasdaq21d
Is DexCom a Millionaire-Maker Stock?
Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps ...
CNN10mon
DexCom, Inc.
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...
Stockhouse28d
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate glucose sensing technology.5 It is specifically designed to provide the 125 million ...